From the Cystic Fibrosis research group at Manchester University. A forum to update public, patients, and other researchers on what we do and why we do it.
Manchester is host to the PULSE-CF Research Innovation Hub, a major new research initiative from @cftrust and @LifeARC . You can find out more about the hub from https://t.co/JdkPRHM0dW and see our new study animation at https://t.co/TZEhcNCqoS
Want to join a brilliant team - we are hiring!
Looking for a new clinical research fellow to join the new CF Research Innovation Hub. Great opportunity to work on CF infections and exacerbations and study for a PhD.
Job link below
https://t.co/eFfZuH7k0k
Right now, most long-term lung conditions are detected when there is irreversible damage to the lungs. Being able to intervene before the damage is permanent is crucial and only possible if we #FundRespiratoryResearch. Read our report on the @ThoraxBMJ: https://t.co/ap7ZPsZIi2
Have you entered our Summer raffle yet? 🌞
Enter by 12 Aug for just £1 and be in with a chance of winning a £2,000!
Every ticket you buy or sell will help us continue to fund essential research to provide life-changing treatments for people with CF.
⛱️ https://t.co/DOvd8pFapU
Today we got accredited! Still awaiting result and full feedback but they did mention that the patient feedback was the best they’d had from any ward they’d done so thank you to all of you who gave us feedback today and through your surveys! & well done to the team on today ⭐️🤞🏼
You can shape the future of research into breathlessness, something that affects everyone living with a lung condition.
Take @ALUK_Research’s short survey to share your research priorities: https://t.co/rRDccJKqTL
Catch up on series two of our #CForYourself podcast with Lucy Baxter.
We're currently planning series 3, so send us your ideas for what you'd like to see covered by emailing [email protected].
➡️ Search 'CForYourself' on your usual podcast provider app to listen.
We're delighted that our Clinical Trials Accelerator Platform was included as an example of a charity-funded research asset by @AMRC in their 'Spotlight on research infrastructure' report last week.
Find out more about CTAP on our website #cfnews
➡️ https://t.co/PZXivqf1HQ
We’ve published final guidance recommending #CysticFibrosis treatments, Kaftrio, Symkevi, and Orkambi, following a new commercial deal between @NHSEngland and Vertex.
Find out more⤵️
https://t.co/GVxHumDVok
Our website has the latest information on Creon, you can check this out via the link in our bio.
Please do get in touch with your CF teams if you are struggling to access Creon from your local pharmacy.
https://t.co/qgs8MJSgtz
By joining our Involvement Group, your voice can be heard by researchers, clinicians, pharmaceutical companies and important regulatory organisations like the MHRA and NICE.
Email [email protected] if you would like to know more about how you can get involved.
We congratulate @Keir_Starmer on his appointment as Prime Minister and look forward to working with @wesstreeting, the new Secretary of State for Health to make people with #cysticfibrosis a priority.